| [1] |
Jone PN, Tremoulet A, Choueiter N, et al. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association[J]. Circulation, 2024, 150(23): e481-e500.
|
| [2] |
Elakabawi K, Lin J, Jiao F, et al. Kawasaki disease: global burden and genetic background[J]. Cardiol Res, 2020, 11(1) : 9-14.
doi: 10.14740/cr993
|
| [3] |
Faim D, Henriques C, Brett A, et al. Kawasaki disease: predictors of resistance to intravenous immunoglobulin and cardiac complications[J]. Arq Bras Cardiol, 2021, 116(3): 485-491.
doi: 10.36660/abc.20190758
pmid: 33470332
|
| [4] |
Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020, 84(8): 1348-1407.
doi: 10.1253/circj.CJ-19-1094
pmid: 32641591
|
| [5] |
Son MBF, Gauvreau K, Newburger JW. Failure of risk prediction modeling for IVIg resistance in Kawasaki disease[J]. Pediatrics, 2023, 151(5): e2022060423.
doi: 10.1542/peds.2022-060423
|
| [6] |
Kim DS. Kawasaki disease[J]. Yonsei Med J. 2006, 47(6): 759-772.
pmid: 17191303
|
| [7] |
黄玉娟, 黄敏. 川崎病静脉注射丙种球蛋白无反应预测模型研究现状[J]. 临床儿科杂志, 2022, 40(7): 481-487.
|
|
Huang YJ, Huang M. Research status of predictive model for IVIg resistance in Kawasaki disease[J]. Linchuang Erke Zazhi, 2022, 40(7): 481-487.
|
| [8] |
Qian W, Tang Y, Yan W, et al. A comparison of efficacy of six prediction models for intravenous immune globulin resistance in Kawasaki disease[J]. Ital J Pediatr, 2018, 44(1): 33.
doi: 10.1186/s13052-018-0475-z
|
| [9] |
Salgado AP, Ashouri N, Berry EK, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease[J]. J Pediatr, 2017, 185: 112-116.
doi: 10.1016/j.jpeds.2017.03.025
|
| [10] |
Kitano N, Takeuchi T, Suenaga T, et al. Seasonal variation in epidemiology of Kawasaki disease-related coronary artery abnormalities in Japan, 1999-2017 [J]. J Epidemiol, 2021, 31(2): 132-138.
doi: 10.2188/jea.JE20190189
|
| [11] |
徐明艳, 邹亚伟, 梁燕锦, 等. 外周血NLR、PLR、SII在婴幼儿川崎病中的临床意义[J]. 中国妇幼健康研究, 2025, 36 (4) : 78-84.
|
|
Xu MY, Zou YW, Liang YJ et al. Clinical values of NLR, PLR and SII in peripheral blood for diagnosis of Kawasaki disease in infants[J]. Zhongguo Fuyou Jiankang Yanjiu, 2025, 36 (4) : 78-84.
|
| [12] |
Jiao F, Pan Y, Du Z, et al. Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China[J]. BMC Pediatr, 2024, 24(1): 477.
doi: 10.1186/s12887-024-04961-2
pmid: 39060924
|
| [13] |
Koliou MG, Aristidou A, Mazeri S, et al. Epidemiology and risk factors for resistance to treatment of Kawasaki disease in Cyprus[J]. Sci Rep, 2023, 13(1): 352.
doi: 10.1038/s41598-023-27694-1
pmid: 36611091
|
| [14] |
Zhao QM, Huang M, Huang MR, et al. Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range[J]. Clin Rheumatol, 2021, 40(4): 1515-1523.
doi: 10.1007/s10067-020-05361-4
|
| [15] |
Ramos M, Seguro Paula F, Carvalho A, et al. Kawasaki disease: a rare case of a non-pediatric patient[J]. Cureus, 2024, 16(11): e74824.
|
| [16] |
穆志龙, 焦富勇, 谢凯生. 《川崎病心血管后遗症的诊断和管理指南(JCS/JSCS 2020)》解读[J]. 中国当代儿科杂志, 2021, 23(3): 213-220.
|
|
Mu ZL, Jiao FY, Xie KS. Interpretation of the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Zhongguo Dangdai Erke Zazhi, 2021, 23(3): 213-220.
|
| [17] |
Galeotti C, Bajolle F, Belot A, et al. French national diagnostic and care protocol for Kawasaki disease[J]. Rev Med Interne, 2023, 44(7): 354-380.
doi: 10.1016/j.revmed.2023.06.002
pmid: 37349225
|
| [18] |
Shi L, Li J, Qie D, et al. Clinical manifestations of Kawasaki disease in different age groups: retrospective data from Southwest China[J]. Clin Rheumatol, 2020, 39(10): 3027-3032.
doi: 10.1007/s10067-020-05069-5
pmid: 32367406
|
| [19] |
Liu HH, Qiu Z, Fan GZ, et al. Assessment of coronary artery abnormalities and variability of Z-score calculation in the acute episode of Kawasaki disease: a retrospective study from China[J]. Eur J Clin Invest, 2021, 51(3): e13409.
doi: 10.1111/eci.v51.3
|
| [20] |
Kitano N, Suzuki H, Takeuchi T. Patient age and the seasonal pattern of onset of Kawasaki’s disease[J]. N Engl J Med, 2018, 378 (21) : 2048-2049.
doi: 10.1056/NEJMc1804312
|
| [21] |
Roh DE, Kwon JE, Kim YH. Bacille calmette-guérin site reactivation of Kawasaki disease in infants under 3 months of age: relation with diagnosis and prognosis[J]. Children (Basel), 2022, 9(6): 857.
|
| [22] |
Kobayashi T, Ayusawa M, Suzuki H, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)[J]. Pediatr Int, 2020, 62(10): 1135-1138.
doi: 10.1111/ped.v62.10
|
| [23] |
李雪琴, 王江涛, 王晓玲, 等. 6月龄以下川崎病患儿发生冠状动脉病变的特点及危险因素分析[J]. 检验医学与临床, 2022, 19(16): 2177-2180.
|
|
Li XQ, Wang JT, Wang XL et al. Analysis of the characteristics and risk factors of coronary artery lesions in children with Kawasaki disease under 6 months of age[J]. Jianyan Yixue Yu Linchuang, 2022, 19(16): 2177-2180.
|
| [24] |
An HS, Kim GB, Song MK, et al. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study[J]. Pediatr Rheumatol Online J, 2021, 19(1): 78.
doi: 10.1186/s12969-021-00566-6
pmid: 34078404
|
| [25] |
Morales-Quispe JA, Espinola-Zavaleta N, Caballero-Caballero R, et al. Clinical evolution and cardiovascular complications in children with Kawasaki disease[J]. Rev Med Inst Mex Seguro Soc, 2011, 49(3): 295-300.
pmid: 21838997
|
| [26] |
Wu S, Long Y, Chen S, et al. A new scoring system for prediction of intravenous immunoglobulin resistance of Kawasaki disease in infants under 1-year old[J]. Front Pediatr, 2019, 7(1): 514.
doi: 10.3389/fped.2019.00514
|
| [27] |
Chen Y, Hua Y, Zhang C, et al. Neutrophil-to-lymphocyte ratio predicts intravenous immunoglobulin-resistance in infants under 12-months old with Kawasaki disease[J]. Front Pediatr, 2019, 7( 1) : 81.
|
| [28] |
Kanai T, Takeshita S, Kawamura Y, et al. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study[J]. Heart Vessels, 2020, 35(10): 1463-1472.
doi: 10.1007/s00380-020-01622-z
pmid: 32449049
|
| [29] |
Li G, Xu X, Chen P, et al. Prognostic value of pretreatment prognostic nutritional index in intravenous immunoglobulin-resistant Kawasaki disease[J]. Heart Vessels, 2021, 36(9): 1366-1373.
doi: 10.1007/s00380-021-01819-w
pmid: 33686555
|
| [30] |
Yi C, Zhou YN, Guo J, et al. Novel predictors of intravenous immunoglobulin resistance in patients with Kawasaki disease: a retrospective study[J]. Front Immunol, 2024, 15: 1399150.
doi: 10.3389/fimmu.2024.1399150
|